FBL and neoplasm: As a downstream target of P53, FBL mediates defects in translation fidelity and IRES-dependent translation initiation, resulting in increased translation of key oncogenes (IGF-1R, C-myc, VEGF-A, and FGF1), ultimately driving tumor initiation and progression [18–21].